Latest Ribbon symbolism Stories
TSX Venture: QPT EDMONTON, Jan. 22, 2013 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has achieved 50% accrual having enrolled the 40(th) patient in its ongoing 80 patient Phase II Oregovomab front-line chemo-immunotherapy clinical trial in Italy and the U.S. The objective of this study is to confirm that optimally dosed oregovomab in...
Cancer cells are resourceful survivors with plenty of tricks for staying alive. Researchers have uncovered one of these stratagems, showing how cells lacking the tumor suppressor BRCA1 can resume one form of DNA repair, sparing themselves from stagnation or death. The study appears in the January 21st issue of The Journal of Cell Biology. The BRCA1 protein helps to mend double-strand DNA breaks by promoting homologous recombination. Without it, cells can amass broken, jumbled, and fused...
Doctors Health Press, a division of Lombardi Publishing Corporation, and publisher of various natural health newsletters, books, and reports, including the popular online Doctors Health Press e-Bulletin, is reporting on a new Yale University study finding that for older women, there is no evidence that breast cancer screenings lead to any benefits. Boston, MA (PRWEB) January 21, 2013 Doctors Health Press, a division of Lombardi Publishing Corporation, and publisher of various natural...
ASSURE Research Project Will Use Volpara to Help Build a Model of Breast Cancer Risk and the Risk of Missing Cancers WELLINGTON, NEW ZEALAND (PRWEB) January 21, 2013 Matakina International is proud to announce the Volpara objective breast density measurement software will be used in the European Union (EU) collaborative Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE) research project. The company will showcase its role in the ASSURE research project...
MONTCLAIR, N.J., Jan. 18, 2013 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis, today announced that the Company will be presenting at the NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference held at the Hard Rock Hotel & Casino, Hollywood, Florida, on Tuesday, January 22, 2013 at 4:30 p.m. Eastern Time. Dr. Oscar Bronsther, Chief Executive Officer...
Medical researchers at the University of Alberta tested the DNA of more than 300 women in Alberta and discovered a 'genetic marker' method to help accurately profile which women were more apt to have their breast cancer return years later. Sambasivarao Damaraju, a professor with the Faculty of Medicine & Dentistry, and at the Cross Cancer Institute just published his team's findings in the peer-reviewed journal, PLoS One. Using a simple blood test, Damaraju and his team, which included...
SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that Laszlo Radvanyi, Ph.D., an Associate Professor in the Department of Melanoma Medical Oncology Research at the University of Texas MD Anderson Cancer Center in Houston, has joined its Scientific Advisory Board. "I am excited to be a part of...
RARITAN, N.J., Jan. 17, 2013 /PRNewswire/ -- Veridex, LLC today announced an agreement with LabCorp Clinical Trials that makes the CELLSEARCH(®) circulating tumor cell (CTC) test available for researchers conducting clinical trials in China. This marks the first clinical reference laboratory in China that offers CTC testing and comes on the heels of China's State Food & Drug Administration approval of CELLSEARCH(®) as an in vitro diagnostic to manage patients with metastatic...
Brett Smith for redOrbit.com – Your Universe Online A new study on breast cancer patients in Spain showed that, despite improving among young and middle aged women, older women still face about the same mortality rate they did in 1992. The study, published in the latest edition of Public Health by a team of Spanish researchers, analyzed breast cancer mortality rates in Spain among different age groups from 1981 to 2007. The group also modeled mortality rates into the future, through...
SAN DIEGO, Jan. 15, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) In 2012, researchers published the discovery that small particles known as exosomes are secreted by tumors to seed the creation and spread of cancer metastases. These same tumor-secreted exosomes have also been implicated in death of immune cells necessary to...
